Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Shifting funds with limited resources requires thoughtful prioritization. This intro provides practical tips to optimize your remaining dollars.
25,048 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
As investors scan the horizon for regenerative medicine players, Avita (RCEL) faces a pivotal quarter. This guide bre...
XRP remains unable to break above $1.30, trading around the mid-$1.1s as traders weigh whether a reclaim $1.30? is wi...
A sharp uptick in Micron's revenue is grabbing attention. This article breaks down what caused the rise, whether it c...
New long-term care products now let many baby boomers access coverage without underwriting, signaling a shift in reti...
Sellers are reasserting control as Ethereum’s relief rally fades, keeping prices range-bound near critical levels and...
Starbucks CEO Brian Niccol says the company drifted into factory-like operations. He outlines a reset designed to rec...
The Trump administration announced a sweeping change: foreigners seeking green cards must leave the United States to ...
XRP confronts a tough week ahead after a weekly rejection, with a bearish setup in play across USD and BTC markets. K...
Foundry rises to the top of the mining race, triggering a rare two-block reorg that tests Bitcoin’s finality. Analyst...
A single trading session can test even solid businesses. This article explains why autozone stock plummeting today ha...